Neurofibromin deficiency in mice causes exencephaly and is a modifier for Splotch neural tube defects

Developmental Biology

Volumn 212, Issue 1, 1999, Pages 80-92

  Lakkis, Maha M ^a   Golden, Jeffrey A ^a   O'Shea, K Sue ^b   Epstein, Jonathan A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Dorsal root ganglia; Exencephaly; Nf1( ); Pax3; Spina bifida

Indexed keywords

FOLIC ACID; NEUROFIBROMIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; ENVIRONMENTAL FACTOR; EXENCEPHALY; FEMALE; GENE LOCUS; GENE MUTATION; HETEROZYGOTE; HOMOZYGOTE; MALE; MOUSE; NEURAL CREST; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPINA BIFIDA; SPINAL GANGLION;

EID: 0033178548     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.1999.9327     Document Type: Article

References (76)

1. Armstrong J. F., Kaufman M. H., Harrison D. J., Clarke A. R. High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5:1995;931-936.
2. Auerbach R. Analysis of the developmental effects of a lethal mutation in the house mouse. J. Exp. Zool. 127:1954;305-329.
3. Ayme S., Philip N. Possible homozygous Waardenburg syndrome in a fetus with exencephaly. Am. J. Med. Genet. 59:1995;263-265.
4. Ballester R., Marchuk D., Boguski M., Saulino A., Letcher R., Wigler M., Collins F. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell. 63:1990;851-859.
5. Bollag G., Clapp D. W., Shih S., Adler F., Zhang Y. Y., Thompson P., Lange B. J., Freedman M. H., McCormick F., Jacks T., Shannon K. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat. Genet. 12:1996;144-148.
6. Brannan C. I., Perkins A. S., Vogel K. S., Ratner N., Nordlund M. L., Reid S. W., Buchberg A. M., Jenkins N. A., Parada L. F., Copeland N. G. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8:1994;1019-1029.
7. Burn J., Gibbens D. May spina bifida result from an X-linked defect in a selective abortion mechanism. J. Med. Genet. 16:1979;210-214.
8. Butterworth C. E. Jr., Bendich A. Folic acid and the prevention of birth defects. Annu. Rev. Nutr. 16:1996;73-97.
9. Chapman C. A., Waber D. P., Bassett N., Urion D. K., Korf B. R. Neurobehavioral profiles of children with neurofibromatosis 1 referred for learning disabilities are sex-specific. Am. J. Med. Genet. 67:1996;127-132.
10. Chatkupt S., Chatkupt S., Johnson W. G. Waardenburg syndrome and myelomeningocele in a family. J. Med. Genet. 30:1993;83-84.
11. Chen Z. F., Behringer R. R. twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 9:1995;686-699.
12. Copp A. J. Genetic models of mammalian neural tube defects. Ciba Found. Symp. 181:1994;118-134.
13. Copp A. J., Brook F. A., Estibeiro J. P., Shum A. S., Cockroft D. L. The embryonic development of mammalian neural tube defects. Prog. Neurobiol. 35:1990;363-403.
14. Crosby J. L., Varnum D. S., Washburn L. L., Nadeau J. H. Disorganization is a completely dominant gain-of-function mouse mutation causing sporadic developmental defects. Mech. Dev. 37:1992;121-126.
15. Daston M. M., Ratner N. Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev. Dyn. 195:1992;216-226.
16. Echelard Y., Epstein D. J., St-Jacques B., Shen L., Mohler J., McMahon J. A., McMahon A. P. Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell. 75:1993;1417-1430.
17. Edmonds L. D., James L. M. Temporal trends in the prevalence of congenital malformations at birth based on the birth defects monitoring program, United States, 1979-1987. MMWR. 39:1990;19-23.
18. Embury S., Seller M. J., Adinolfi M., Polani P. E. Neural tube defects in curly-tail mice. I. Incidence, expression and similarity to the human condition. Proc. R. Soc. London B Biol. Sci. 206:1979;85-94.
19. Epstein D. J., Vekemans M., Gros P. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell. 67:1991;767-774.
20. Epstein J. A., Lam P., Jepeal L., Maas R. L., Shapiro D. N. Pax3 inhibits myogenic differentiation of cultured myoblast cells. J. Biol. Chem. 270:1995;11719-11722.
21. Estibeiro J. P., Brook F. A., Copp A. J. Interaction between splotch (Sp) and curly tail (ct) mouse mutants in the embryonic development of neural tube defects. Development. 119:1993;113-121.
22. Ewart J., Cohen M., Meyer R., Huang G., Wessels A., Gourdie R., Chin A., Park S., Lazatin B., Villabon S., Lo C. Heart and neural tube defects in transgenic mice overexpressing the Cx43 gap junction gene. Development. 124:1997;1281-1292.
23. Fleming A., Copp A. J. Embryonic folate metabolism and mouse neural tube defects. Science. 280:1998;2107-2109.
24. Franz T. Persistent truncus arteriosus in the Splotch mutant mouse. Anat. Embryol. 180:1989;457-464.
25. Golden J. A., Chernoff G. F. Intermittent pattern of neural tube closure in two strains of mice. Teratology. 47:1993;73-80.
26. Goulding M. D., Chalepakis G., Deutsch U., Erselius J. R., Gruss P. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10:1991;1135-1147.
27. Grinspan J. B., Marchionni M. A., Reeves M., Coulaloglou M., Scherer S. S. Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: Neuregulin receptors and the role of neuregulins. J. Neurosci. 16:1996;6107-6118.
28. Gunn T. M., Juriloff D. M., Harris M. J. Further genetic studies of the cause of exencephaly in SELH mice. Teratology. 45:1992;679-686.
29. Gunther T., Struwe M., Aguzzi A., Schughart K. Open brain, a new mouse mutant with severe neural tube defects, shows altered gene expression patterns in the developing spinal cord. Development. 120:1994;3119-3130.
30. Gutmann D. H., Aylsworth A., Carey J. C., Korf B., Marks J., Pyeritz R. E., Rubenstein A., Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 278:1997;51-57.
31. Gutmann D. H., Cole J. L., Collins F. S. Expression of the neurofibromatosis type 1 (NF1) gene during mouse embryonic development. Prog. Brain Res. 105:1995;327-335.
32. Harris B. S., Franz T., Ullrich S., Cook S., Bronson R. T., Davisson M. T. Forebrain overgrowth (fog): A new mutation in the mouse affecting neural tube development. Teratology. 55:1997;231-240.
33. Harris M. J., Juriloff D. M. Genetic landmarks for defects in mouse neural tube closure. Teratology. 56:1997;177-187.
34. Hattori S., Maekawa M., Nakamura S. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21. Oncogene. 7:1992;481-485.
35. Helwig U., Imai K., Schmahl W., Thomas B. E., Varnum D. S., Nadeau J. H., Balling R. Interaction between undulated and Patch leads to an extreme form of spina bifida in double-mutant mice. Nat. Genet. 11:1995;60-63.
36. Henkemeyer M., Rossi D. J., Holmyard D. P., Puri M. C., Mbamalu G., Harpal K., Shih T. S., Jacks T., Pawson T. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature. 377:1995;695-701.
37. Homanics G. E., Maeda N., Traber M. G., Kayden H. J., Dehart D. B., Sulik K. K. Exencephaly and hydrocephaly in mice with targeted modification of the apolipoprotein B (Apob) gene. Teratology. 51:1995;1-10.
38. Huynh D. P., Nechiporuk T., Pulst S. M. Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Dev. Biol. 161:1994;538-551.
39. Jacks T., Shih T. S., Schmitt E. M., Bronson R. T., Bernards A., Weinberg R. A. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat. Genet. 7:1994;353-361.
40. Juriloff D. M., Macdonald K. B., Harris M. J. Genetic analysis of the cause of exencephaly in the SELH/Bc mouse stock. Teratology. 40:1989;395-405.
41. Kim H. A., Ling B., Ratner N. Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: Reversion of some phenotypes by an inhibitor of farnesyl protein transferase. Mol. Cell. Biol. 17:1997;862-872.
42. Kim H. A., Rosenbaum T., Marchionni M. A., Ratner N., DeClue J. E. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes. Oncogene. 11:1995;325-335.
43. Kioussi C., Gross M. K., Gruss P. Pax3: A paired domain gene as a regulator in PNS myelination. Neuron. 15:1995;553-562.
44. Labosky P. A., Winnier G. E., Jetton T. L., Hargett L., Ryan A. K., Rosenfeld M. G., Parlow A. F., Hogan B. L. The winged helix gene, Mf3, is required for normal development of the diencephalon and midbrain, postnatal growth and the milk-ejection reflex. Development. 124:1997;1263-1274.
45. Lakkis M. M., Epstein J. A. Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development. 125:1998;4359-4367.
46. Laurence K. M., Dew J. O., Dyer C., Downey K. H. Amniocentesis carried out for neural tube indications in South Wales 1973-1981: Outcome of pregnancies and findings in the malformed abortuses. Prenat. Diagn. 3:1983;187-201.
47. Lemire R. J. Neural tube defects. J. Child. Neurol. 3:1988;2-46.
48. Lutz B., Kuratani S., Cooney A., Wawersik S., Tsai S. Y., Eichele G., Tsai M. Developmental regulation of the orphan receptor COUP-TFII gene in spinal motor neurons. Development. 120:1994;25-36.
49. Martin G. A., Viskochil D., Bollag G., McCabe P. C., Crosier W. J., Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R. M., Innis M. A., McCormick F. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell. 63:1990;843-849.
50. Moase C. E., Trasler D. G. N-CAM alterations in splotch neural tube defect mouse embryos. Development. 113:1991;1049-1058.
51. Nakano K. K. Anencephaly: A review. Dev. Med. Child. Neurol. 15:1973;383-400.
52. Neumann P. E., Frankel W. N., Letts V. A., Coffin J. M., Copp A. J., Bernfield M. Multifactorial inheritance of neural tube defects: Localization of the major gene and recognition of modifiers in ct mutant mice. Nat. Genet. 6:1994;357-362.
53. Nordlund M., Gu X., Shipley M. T., Ratner N. Neurofibromin is enriched in the endoplasmic reticulum of CNS neurons. J. Neurosci. 13:1993;1588-1600.
54. Nordlund M. L., Rizvi T. A., Brannan C. I., Ratner N. Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains. J. Neuropathol. Exp. Neurol. 54:1995;588-600.
55. Nye J. S., Balkin N., Lucas H., Knepper P. A., McLone D. G., Charrow J. Myelomeningocele and Waardenburg syndrome (type 3) in patients with interstitial deletions of 2q35 and the PAX3 gene: Possible digenic inheritance of a neural tube defect. Am. J. Med. Genet. 75:1998;401-408.
56. Page D. C., Mosher R., Simpson E. M., Fisher E. M., Mardon G., Pollack J., McGillivray B., de la Chapelle A., Brown L. G. The sex-determining region of the human Y chromosome encodes a finger protein. Cell. 51:1987;1091-1104.
57. Richards I. D., McIntosh H. T., Sweenie S. A genetic study of anencephaly and spina bifida in Glasgow. Dev. Med. Child. Neurol. 14:1972;626-639.
58. Rosenbaum C., Karyala S., Marchionni M. A., Kim H. A., Krasnoselsky A. L., Happel B., Isaacs I., Brackenbury R., Ratner N. Schwann cells express NDF and SMDF/n-ARIA mRNAs, secrete neuregulin, and show constitutive activation of erbB3 receptors: Evidence for a neuregulin autocrine loop. Exp. Neurol. 148:1997;604-615.
59. Sah V. P., Attardi L. D., Mulligan G. J., Williams B. O., Bronson R. T., Jacks T. A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet. 10:1995;175-180.
60. Said S. M., Yeh T. L., Greenwood R. S., Whitt J. K., Tupler L. A., Krishnan K. R. MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis. NeuroReport. 7:1996;1941-1944.
61. Schorle H., Meier P., Buchert M., Jaenisch R., Mitchell P. J. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature. 381:1996;235-238.
62. Shou W., Aghdasi B., Armstrong D. L., Guo Q., Bao S., Charng M. J., Mathews L. M., Schneider M. D., Hamilton S. L., Matzuk M. M. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature. 391:1998;489-492.
63. Silva A. J., Frankland P. W., Marowitz Z., Friedman E., Lazlo G., Cioffi D., Jacks T., Bourtchuladze R. A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat. Genet. 15:1997;281-284.
64. Steck P. A., Saya H. Pathways of oncogenesis in primary brain tumors. Curr. Opin. Oncol. 3:1991;476-484.
65. Stoykova A., Gruss P. Roles of Pax-genes in developing and adult brain as suggested by expression patterns. J. Neurosci. 14:1994;1395-1412.
66. Tajbakhsh S., Rocancourt D., Cossu G., Buckingham M. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and myf-5 act upstream of myoD. Cell. 89:1997;127-138.
67. Takahashi K., Suzuki H., Kayama T., Suzuki Y., Yoshimoto T., Sasano H., Shibahara S. Multiple transcripts of the neurofibromatosis type 1 gene in human brain and in brain tumours. Clin. Sci. (Colchester). 87:1994;481-485.
68. Tassabehji M., Read A. P., Newton V. E., Harris R., Balling R., Gruss P., Strachan T. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature. 355:1992;635-636.
69. Thomas K. R., Musci T. S., Neumann P. E., Capecchi M. R. Swaying is a mutant allele of the proto-oncogene Wnt-1. Cell. 67:1991;969-976.
70. Vogel K. S., Brannan C. I., Jenkins N. A., Copeland N. G., Parada L. F. Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell. 82:1995;733-742.
71. Vogel K. S., Parada L. F. Sympathetic neuron survival and proliferation are prolonged by loss of p53 and neurofibromin. Mol. Cell. Neurosci. 11:1998;19-28.
72. Vogelweid C. M., Vogt D. W., Besch-Williford C. L., Walker S. E. New Zealand White mice: An experimental model of exencephaly. Lab. Anim. Sci. 43:1993;58-60.
73. Xu G., O'Connell P., Viskochil D., Cawthon R., Robertson M., Culver M., Dunn D., Stevens J., Gesteland R., White R., Weiss R. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 62:1990;599-608.
74. Xu W., Baribault H., Adamson E. D. Vinculin knockout results in heart and brain defects during embryonic development. Development. 125:1998;327-337.
75. Zhang J., Hagopian-Donaldson S., Serbedzija G., Elsemore J., Plehn-Dujowich D., McMahon A. P., Flavell R. A., Williams T. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature. 381:1996;238-241.
76. Zhao G. Q., Eberspaecher H., Seldin M. F., de Crombrugghe B. The gene for the homeodomain-containing protein Cart-1 is expressed in cells that have a chondrogenic potential during embryonic development. Mech. Dev. 48:1994;245-254.